Navigation Links
HIV mortality in India drops with introduction of generic antiretroviral therapy

The survival rate of HIV-infected patients in India has risen in response to a 20-fold drop in the price of antiretroviral therapy (ART), according to an article in the Nov. 15 issue of Clinical Infectious Diseases, now available online. The introduction of generic drugs into the country has encouraged people to seek HIV treatment because of the cheaper cost, the article states.

Many of the more than 5 million HIV-infected people living in India have been unable to obtain treatment due to the high cost. With the introduction of generic ART into India in 2000, the price of HIV drugs fell from $778 per month to $100 per month, and eventually declined even further to just $33 per month in 2003.

The drastically lower cost of ART sparked a rise in the number of people seeking--and obtaining--treatment for their infection. Researchers in India and Rhode Island found that in 1996, just 13 percent of the Indian patients who qualified for ART were able to afford it. But that number rose to 22 percent in 2000, and reached 44 percent in 2003.

With the availability of much-needed drugs came better health. Opportunistic infections such as tuberculosis, a common problem for immunocompromised patients, occur at a much lower rate in those receiving ART and its highly active drug counterpart, HAART. Accessible drugs have led, in part, to an 80 percent decline in HIV-related deaths in India between 1997 and 2003.

Despite ART's importance in improving HIV-infected people's health, it can also cause problems. Adverse events, such as rash, nausea, diarrhea, headache and anemia, can arise from antiretroviral use. But are the side effects serious enough to discourage patients from continuing ART? "No. Benefits of HAART outweigh the toxicities, based on our experience in our patients," said lead author Nagalingeswaran Kumarasamy, PhD, of the YRG Centre for AIDS Research and Education in Chennai.

Along with the much cheaper price of ART--which can be
'"/>

Source:Infectious Diseases Society of America


Page: 1 2

Related biology news :

1. Oil spills and climate change double the mortality rate of British seabirds
2. US infant mortality rate fails to improve
3. Quitting smoking reduces risk of lung cancer mortality by 70 percent
4. Indias smoking gun: Dino-killing eruptions
5. Genetic analysis of Asian elephants in India reveals some surprises
6. Alcoholism, smoking and genetics among Plains American Indians
7. Researchers make progress in studying genetic traits of India-born populations
8. New technologies coming too fast for Indian farmers
9. Ring-like formations in drying DNA drops could affect hybridization studies
10. FDA approves more generic AIDS drugs
11. International HIV/AIDS trial finds continuous antiretroviral therapy superior to episodic therapy
Post Your Comments:
(Date:11/4/2014)... (Philadelphia, PA) – Temple University School of Medicine ... Explorations winner, an initiative funded by the Bill ... MPH, Professor of Obstetrics, Gynecology and Reproductive Sciences; ... at Temple University School of Medicine will pursue ... titled "Maternal Blood Biomarkers to Assess Fetal Neurodevelopment.", ...
(Date:11/4/2014)... 2014   3D ... Fuel3D , a developer of 3D scanning ... totaling $6.4 million (£4 million). This funding builds on the ... year and paves the way for the commercial launch of ... funding round was led by Chimera Partners and will be ...
(Date:11/3/2014)... Research and Markets has announced the addition of ... Companies" to their offering. This report ... already started to play an important role in the practice ... fashioned bone marrow transplants. Role of cells in drug discovery ... part of medical practice. Stem cells are discussed ...
Breaking Biology News(10 mins):Temple University School of Medicine receives Grand Challenges Explorations grant 2Fuel3D Secures $6.4 Million in Expansion Funding 2Fuel3D Secures $6.4 Million in Expansion Funding 3Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 2Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 3
... February 23, 2009 - A new study by ... Panel on Climate Change (IPCC) 2001 Third Assessment Report ... average global temperatures due to greenhouse gas emissions could ... concern. The study, published in the Proceedings of ...
... California Institute of Technology (Caltech) and the University of ... theoretical modeling and Caltech experimental data to show just ... functional proteins. Their insights were recently published in ... the National Academy of Sciences (PNAS). The ...
... Maybe. A team of European scientists have finally solved a ... gray. Despite the notion that gray hair is a sign of ... The FASEB Journal ( http://www.fasebj.org ) that wisdom has ... massive build up of hydrogen peroxide due to wear and tear ...
Cached Biology News:Lower increases in global temps could lead to greater impacts than previously thought, study finds 2Lower increases in global temps could lead to greater impacts than previously thought, study finds 3Caltech and UCSD researchers shed light on how proteins find their shapes 2No longer a gray area: Our hair bleaches itself as we grow older 2
(Date:11/26/2014)... 26, 2014 In keeping with the ... a bevy of last-minute Thanksgiving savings. The company is ... across all product lines this holiday weekend as well ... Black Friday, and Cyber Monday are right around the ... to both loyal customers and those looking to explore ...
(Date:11/26/2014)... Nov. 26, 2014 The Alliance ... a survey of European physicians at the "1 ... and Biological Therapies" at the Spanish Ministry of ... by EuropaBio and the Spanish Bioindustry Association (ASEBIO), ... physicians from Spanish oncology and rheumatology societies, representatives ...
(Date:11/26/2014)... 26, 2014 PMG Research, Inc. ... Research is a network of sites that provide clinical research ... 2 million patient lives through its partnerships with large physician ... 11 hub site locations in the Southeastern United States and ... of the board will be held by: Dr. ...
(Date:11/26/2014)... Silicon Valley Electronic Data Capture (EDC) ... Alliance , provider of clinical research and data management ... addition to its CRO Partnership Program, Clinovo expands ... India. , “We have found Clinovo’s ClinCapture to ... platform which is both user friendly and easy to ...
Breaking Biology Technology:DNA Spectrum Offers Last Minute Thanksgiving Coupons 2DNA Spectrum Offers Last Minute Thanksgiving Coupons 3ASBM Presents European Physicians Survey at Spanish Ministry of Health 2PMG Research Names Medical Advisory Board 2PMG Research Names Medical Advisory Board 3RPM Alliance Joins Clinovo’s CRO Partnership Program, Further Strengthening Its Presence in Southern California and India 2
... a subsidiary of MGT Capital Investments, Inc. (NYSE Alternext ... of Computer-Aided Detection (CAD) and image analysis software which ... is pleased to announce it has launched ColonCAD API ... today at the European Congress of Radiology (ECR 2009) ...
... All amounts are in US dollarsQUEBEC CITY, March ... AEZS ; TSX: AEZ), a global biopharmaceutical ... announced the signing of a development, commercialization and ... SNY ) for the development, registration and ...
... in the two years since its discovery, has spread to ... half a million bats. Now researchers have suggested the first ... bats: providing localized heat sources to the hibernating animals. ... says Justin Boyles, a graduate student in biology at Indiana ...
Cached Biology Technology:Medicsight Unveils New Version of ColonCAD(TM) at ECR 2009 2Medicsight Unveils New Version of ColonCAD(TM) at ECR 2009 3AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia 2AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia 3AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia 4AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia 5Ecologists propose first prevention for white-nose syndrome death in bats 2Ecologists propose first prevention for white-nose syndrome death in bats 3
Recombinant Ovine (Sheep) Prolactin, Ultra Pure...
Human SCP3 Affinity Purified Polyclonal Ab Keywords: Spermatogenesis, meiosis Protein Family: Cell Cycle...
Homo sapiens alcohol dehydrogenase 5 (class III), chi polypeptide (ADH5), mRNA....
Human Rad1 MAb (Clone 33)...
Biology Products: